Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Treviso
Clinical trial register · Italy

Clinical Trials in Treviso, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 2855 Bologna 1282 Roma 1266 Naples 983 Rome 968

Trials with a site in Treviso

22 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca
Phase 3
600
Milan, Monza, Naples, Rome, Torino, Treviso
2026-09-24
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
Meldola, Milan, Novara, Pavia, Perugia, Prato, Siena, Treviso
2026-01-12
Recruiting
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison
NCT07259291Propofol, Anesthesia Brain Monitoring, Remifentanil
University of Padova
Observational
100
Treviso
2025-11-25
Recruiting
Treviso Regional Hospital
Observational
50
Treviso
2025-05-08
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT06906341Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms, Endometrial Cancer
Corcept Therapeutics
Phase 2
270
Catania, Milan, Pavia, Rome, Torino, Treviso
2025-04-11
Recruiting
TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI
NCT05873842Trans-femoral TAVI With Calcified Ilio-femoral Arteries
Rede Optimus Hospitalar SA
Observational
50
Ancona, Mestre, Treviso, Verona, Vicenza
2024-07-22
Recruiting
Impact of Estimated Concentration of Propofol on Implicit Memory Formation
NCT06497855General Anaesthesia, Implicit Memory
University of Padova
Observational
80
Treviso
2024-07-01
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Bergamo, Bologna, Genova, Milan, Pavia, Rome, Treviso
2024-06-25
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Bari, Catania, Padova, Treviso
2023-10-17
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
68
Perugia, Rome, Treviso
2023-06-12
Recruiting
IRCCS Eugenio Medea
Not applicable
200
Bosisio Parini, Conegliano, Treviso
2023-02-16
Active, closed
Corcept Therapeutics
Phase 3
381
Catania, Legnago, Milan, Pavia, Roma, Rome, Torino, Treviso
2022-06-29
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Ancona, Cremona, Empoli, Florence, Milan, Perugia, Treviso
2021-08-04
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
72
Bologna, Bolzano, Castelfranco Veneto, San Giovanni Rotondo, Treviso
2021-06-09
Active, closed
Balt Extrusion
Observational
234
Milan, Monza, Treviso, Udine
2019-11-04
Recruiting
Post Operative Cognitive Dysfunction After Oncologic Surgery
NCT03774420Emergence Delirium, Post-Operative Cognitive Dysfunction
University of Padova
Observational
200
Treviso
2019-07-03
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Milan, Padova, Florence, Genova, Treviso
2019-05-09
Active, closed
ECOG-ACRIN Cancer Research Group
Phase 3
108,508
Treviso
2017-09-28
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy/city/treviso

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Treviso.

How many clinical trials are recruiting in Treviso?

14 of the 22 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Treviso), 22 studies
PhaseStudiesRecruitingShare
Observational9840.9%
Phase 38436.4%
Phase 23113.6%
Not applicable219.1%

Most active sponsors

Lead sponsors with the most studies (Treviso)
Lead sponsorStudiesRecruiting
University of Padova44
AstraZeneca22
Corcept Therapeutics21
ETOP IBCSG Partners Foundation21
Assistance Publique - Hôpitaux de Paris10
Balt Extrusion10
ECOG-ACRIN Cancer Research Group10
Gruppo Italiano Malattie EMatologiche dell'Adulto10
Guerbet11
IRCCS Eugenio Medea11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.